PT-141 Spray 10mg is a research-grade intranasal peptide formulation developed to support laboratory investigations involving melanocortin receptor biology, neuropeptide signaling, molecular pharmacology, peptide chemistry, intracellular communication, formulation science, and neuroscience research. The active peptide, PT-141 (Bremelanotide), is a synthetic cyclic melanocortin analog derived from α-melanocyte-stimulating hormone (α-MSH). Because of its unique molecular structure and receptor selectivity, PT-141 has become one of the most extensively investigated peptides within melanocortin research. The standardized intranasal spray formulation enables researchers to investigate peptide stability, receptor interactions, analytical performance, and formulation characteristics under controlled laboratory conditions.
A primary focus of PT-141 research centers on the melanocortin receptor family, particularly MC3R and MC4R, both members of the G protein-coupled receptor (GPCR) superfamily. Researchers investigate receptor activation, ligand binding, intracellular signaling, receptor selectivity, and downstream molecular responses to better understand melanocortin-mediated cellular communication. These investigations contribute to broader scientific understanding of GPCR biology while remaining exclusively within Research Use Only laboratory applications.
Researchers also investigate PT-141 in relation to intracellular signaling pathways involving cyclic AMP (cAMP), protein kinase A (PKA), ERK/MAPK, PI3K/Akt, transcriptional regulation, and peptide-mediated molecular communication. Scientific studies continue exploring how melanocortin receptor activation influences intracellular messenger systems, kinase signaling, and coordinated cellular responses in experimental models.
The intranasal spray formulation provides additional scientific value by allowing laboratories to investigate formulation stability, spray consistency, peptide integrity, physicochemical characteristics, analytical reproducibility, and intranasal delivery system performance. Comparative laboratory investigations frequently evaluate intranasal formulations alongside lyophilized peptide preparations to better understand formulation behavior, analytical properties, stability profiles, and standardized laboratory handling procedures.
PT-141 Spray is commonly investigated alongside Melanotan I, Melanotan II, α-MSH analogs, Semax, Selank, and additional neuroactive or melanocortin-related investigational peptides. Comparative laboratory studies evaluate receptor specificity, intracellular signaling pathways, molecular stability, peptide pharmacology, formulation science, and analytical chemistry to better understand similarities and distinctions among melanocortin peptide systems.
The 10mg formulation is particularly valuable for laboratories conducting receptor biology investigations, GPCR signaling studies, formulation comparison research, peptide characterization, biomarker discovery, molecular pharmacology investigations, analytical validation, neuroscience experiments, and peptide formulation development requiring standardized intranasal investigational materials.
Beyond receptor biology investigations, PT-141 Spray serves as an important analytical reference material within peptide chemistry, molecular biology, analytical chemistry, pharmaceutical analysis, proteomics, biochemistry, formulation science, drug delivery research, and systems biology. Its well-characterized cyclic peptide structure and expanding scientific literature make it valuable for analytical method development, receptor biology investigations, formulation comparison studies, and laboratory quality assurance.
Each batch of PT-141 Spray 10mg is manufactured according to stringent research-grade production standards and undergoes comprehensive analytical verification before release. Quality assurance procedures include peptide identity confirmation, analytical purity verification, formulation consistency evaluation, packaging inspection, microbial quality testing where appropriate, and batch-specific quality control documentation. These procedures support reproducibility, consistency, and confidence across independent laboratory investigations.
To preserve formulation quality, PT-141 Spray should be stored according to accepted laboratory recommendations for peptide formulations. Appropriate storage conditions, controlled laboratory handling, and adherence to institutional protocols help maintain formulation integrity before analytical evaluation and experimental use.
Although PT-141 remains one of the most extensively investigated melanocortin peptides, research involving melanocortin receptor biology, GPCR signaling, cAMP-mediated intracellular communication, formulation science, and intranasal peptide delivery continues to evolve. Accordingly, PT-141 Spray 10mg should be regarded exclusively as an investigational laboratory material intended to support scientific discovery and analytical research.
PT-141 Spray 10mg is supplied exclusively for laboratory research and analytical applications. This product is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary applications, cosmetic use, or diagnostic purposes.
